Homozygous Familial Hypercholesterolemia Information and Resources

Fund Status and Eligibility

Fully Allocated - Effective 06/20/2019, we are unable to process applications that are pending or accept new or renewal applications at this time. Should additional funding for Homozygous Familial Hypercholesterolemia Fund applicants become available in the future, it will be necessary to re-apply if assistance is still needed.

Maximum Award Level: $4,500 Per Year

Eligibility Criteria

  • Patient must be insured and insurance must cover the medication for which patient seeks assistance.
  • Patient must have a confirmed diagnosis of Homozygous Familial Hypercholesterolemia .
  • Patient must reside and receive treatment in the United States.
  • Patient's income must fall below 400% of the Federal Poverty Guideline (FPG) with consideration of the Cost of Living Index (COLI) and the number in the household.

Get Help With Your Treatment: How to Apply Online

Information About the Disease

Familial hypercholesterolemia is a genetic disorder characterized by high cholesterol levels, specifically very high levels of low-density lipoprotein, in the blood and early cardiovascular disease. Homozygous Familial Hypercholesterolemia (HoFH) is a rare, but very severe form of an inherited disorder resulting from a genetic mutation on chromosome number 19. This mutation makes the liver incapable of metabolizing cholesterol, specifically low-density lipoprotein (LDL), resulting in very high LDL levels. The disorder leads to aggressive atherosclerosis, which if left untreated, causes individuals to experience heart attacks or death before age 30. Many patients with homozygous FH must undergo LDL apheresis on a regular basis. LDL Apheresis is a process by which blood is removed, LDL-C is filtered out, and then the person’s blood is returned to their body. It is similar to dialysis. This form of familial hypercholesterolemia occurs in about 1 in 160,000 to one million people worldwide.

Homozygous Familial Hypercholesterolemia Resources

PAF's National Underinsured Resource Directory


Acute Coronary Syndrome: Stroke and Heart Attack Prevention (Interactive Patient Resource developed by The FH Foundation, the Association of Black Cardiologists and Krames Staywell)


American Academy of Pediatrics


American College of Cardiology


American Heart Association


American Lung Association


Familial Hypercholesterolemia


Familial Hypercholesterolemia Diagnosis app for iPhone


Familial Hypercholesterolemia Journeys


Genes in Life (Find out more about the relationship between health and genetics)


Genetics in Primary Care Institute (American Academy of Pediatrics)


Global Genes Project


Global Genes Toolkits


International Familial Hypercholesterolemia Foundation


MEDPED – Make Early Diagnosis to Prevent Early Death


National Institutes of Health


National Lipid Association


National Society of Genetic Counselors


Preventive Cardiac Nurses Association (PCNA)



The Patient Advocate Foundation's (PAF) Co-Pay Relief (CPR) Program does not review the information contained on the website links provided for content, accuracy or completeness. Use of and access to this information is subject to the terms, limitations and conditions as outlined on the accessed websites.

PAF Co-Pay Relief Program makes no representation as to the accuracy or any other aspect of the information contained on any website accessed from the CPR website, nor does PAF Co-Pay Relief Program necessarily endorse the website information provided.

The information presented on the PAF Co-Pay Relief website is provided for general information only and is not intended as a substitute for medical care. Please talk with your healthcare provider about any information you acquire from this or any other website accessed through the PAF Co-Pay Relief program website.